INTERNATIONAL BIOMEDICAL RESEARCH ALLIANCE (EIN 203382296) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

AUSTIN SWAFFORD

Phone

7714441353

Tax Period

2024-01-01 to 2024-12-31

INTERNATIONAL BIOMEDICAL RESEARCH ALLIANCE, founded in 2005, is a small nonprofit in the Medical Research sector that reported $293K in total revenue in fiscal year 2024. Revenue surged 42% from the prior year, signaling strong growth momentum. Expenses of $547K exceeded revenue, resulting in a 87% operating deficit.

Mission

WE EMPOWER PROMISING BIOMEDICAL RESEARCHERS THROUGH: A) FINANCIALLY SUPPORTING INTERNATIONAL COLLABORATIVE RESEARCH B) PROVIDING PROFESSIONAL & CAREER DEVELOPMENT C) CREATING A WELL-RESOURCED NETWORKING PLATFORM

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $278,773

Program Service Revenue $0

Investment Income $767

Other Revenue $13,061

TOTAL REVENUE $292,601

Expense Breakdown

Grants Paid $48,383

Salaries & Benefits $254,407

Fundraising Expenses $51,455

Program Expenses $355,508

Other Expenses $244,642

TOTAL EXPENSES $547,432

Year-over-Year Comparison

	2024	2023	Change
Revenue	$292,601	$206,198	+0.4%
Expenses	$547,432	$376,791	+0.5%
Net Income	$-254,831	$-170,593	+0.5%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$140,000

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
STEPHEN M MCLEAN	CHAIRMAN	6.25	Officer Director	$0	$0	$0
KATHRYN ZOON PHD	VICE CHAIR	6.25	Officer Director	$0	$0	$0
ALAN K JONES	TREASURER	3.75	Officer Director	$0	$0	$0
BRIAN ATWOOD	DIRECTOR	1.25	Director	$0	$0	$0
BRIAN BRILLE	DIRECTOR	2.50	Director	$0	$0	$0
JEREMY P GOLDBERG	DIRECTOR	2.50	Director	$0	$0	$0
SABRINA HEMAN-ACKAH MD PHD	ALUMNI DIRECTOR	1.25	Director	$0	$0	$0
ADAM KNIGHT PHD	ALUMNI DIRECTOR	0.62	Director	$0	$0	$0
SCOTT KOENIG MD	DIRECTOR	2.50	Director	$0	$0	$0
RALPH KORPMAN MD	DIRECTOR	1.25	Director	$0	$0	$0
JUSTIN LATHIA PHD	ALUMNI DIRECTOR	1.25	Director	$0	$0	$0
GEOFFREY LYNN	DIRECTOR	5.00	Director	$0	$0	$0
JOHN NIEDERHUBER MD	DIRECTOR	1.25	Director	$0	$0	$0
RONALD RICHARD	DIRECTOR	2.50	Director	$0	$0	$0
PENELOPE ROSE	DIRECTOR, THRU OCT 2024	0.50	Director	$0	$0	$0
CORALIE VIOLLET	ALUMNI DIRECTOR	2.50	Director	$0	$0	$0
RUPERT VESSEY BM BCH DPHIL	DIRECTOR	2.50	Director	$0	$0	$0
AUSTIN SWAFFORD PHD	PRESIDENT	40.00	Officer	$140,000	$0	$140,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$292,601	$547,432	$114,478	$-254,831
2023	$206,198	$376,791	$324,062	$-170,593
2022	$1,009,928	$1,046,986	$496,275	$-37,058
2021	$304,361	$166,253	$532,357	$138,108
2020	$286,597	$205,150	$391,805	$81,447
2019	$271,832	$263,730	$314,140	$8,102
2018	$257,944	$204,700	$300,757	$53,244

INTERNATIONAL BIOMEDICAL RESEARCH ALLIANCE